Ground-breaking innovations are upending medicine every day, as new technologies, treatments and therapies are developed. Gene therapy holds the potential to revolutionize healthcare as we know it, offering new solutions to illnesses that defied existing treatment plans. Beyond the obvious patient implications, the field is also poised to be a strong growth opportunity for the biotech and pharmaceutical sectors. In this special briefing event, Bloomberg will convene the leaders and experts shaping the future of gene therapy for a conversation on the benefits and risk factors that will affect the regulation, manufacture and application of these therapies as stakeholders work to bring them to scale. This event will discuss bringing regenerative medicine, cell therapy and IPSCs to scale.